Axil Capital

Axil Capital is a global life sciences venture capital firm based in Tokyo. It invests in biomedical and healthcare technology companies from seed through crossover stages - the latter referring to the late-stage rounds typically raised in advance of, or alongside, an initial public offering. The firm has invested in more than 30 companies to date across regions and subsectors.

Investment activity is concentrated in life sciences, biomedical technology and healthcare technology. The firm describes its mandate as backing founders and companies advancing medical care and life-science innovation, and positions its support as active - combining capital with expertise and a global network to help portfolio companies build commercially viable businesses. The team brings together venture capital, finance and scientific research backgrounds.

Axil Capital operates from two Tokyo locations: a head office in Minato-ku and a technology and innovation centre in Chuo-ku. Its stated geographic presence is global, with founders and operators able to make contact through the Tokyo offices.